⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTX News
BioNTech SE American Depositary Share
XBOW任命WonLae Lee為韓國區總經理
businesswire.com
GOOG
MSFT
AMZN
META
NVDA
IBM
ORCL
CSCO
ADBE
CRM
INTC
AMD
QCOM
MU
AMAT
LRCX
KLAC
TXN
ADI
NXPI
ON
MPWR
AEHR
TER
ASML
AMGN
GILD
BIIB
REGN
VRTX
BMY
PFE
MRK
JNJ
ABBV
LLY
XOM
CVX
SHEL
BABA
JD
NTES
PDD
VIPS
HTHT
BEKE
EDU
RLX
LI
XPEV
NIO
CPT
TCOM
RBLX
TTD
MELI
PYPL
COIN
HOOD
UPST
SOFI
AFRM
PLTR
SNOW
DDOG
CRWD
PANW
FTNT
OKTA
CHKP
FFIV
HPQ
DELL
HPE
ACN
CGC
ACB
TLRY
CRON
OGI
SPCE
RKLB
ASTS
PLD
AMT
EQIX
CCI
SBAC
TMUS
VZ
EA
TTWO
U
CRSP
EDIT
NTLA
AZN
BNTX
MRNA
TMO
DHR
GOOGL
AAPL
TSLA
NFLX
DIS
CMCSA
PEP
KO
MCD
WMT
COST
TGT
HD
LOW
CHTR
T
SBUX
NKE
MGM
LVS
WYNN
CCL
RCL
NCLH
AAL
UAL
DAL
LUV
BA
GD
LMT
RTX
NOC
HON
GE
MMM
CAT
DE
AGCO
CNH
IR
SNA
TT
ETN
ROK
EMR
AXP
V
MA
BAC
JPM
WFC
C
GS
MS
SCHW
USB
PNC
BBT
STI
KEY
FITB
HBAN
RF
ZION
AXSM
ALKS
TEVA
BMRN
IDXX
EL
LULU
CPRI
PVH
RL
KSS
BBY
DLTR
DG
TJX
ROST
ULTA
MDT
SYK
ISRG
EW
ABT
BSX
XRAY
CTAS
PAYX
ADP
FIS
FISV
Exploring Investment Opportunities in the Expanding RNA Therapy Clinical Trials Market: A USD 4.28 Billion Valuation by 2031
globenewswire.com
MRNA
BNTX
WVE
U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships
globenewswire.com
PFE
BMY
BNTX
Lateral Flow Assay Market Projected to Reach US$ 17.66 Billion by 2035, Reflecting Ongoing Innovation and IP Activity | Astute Analytica
globenewswire.com
QDEL
ABT
JNJ
BDX
MDT
BNTX
MRNA
mRNA Quality Monitoring Market Forecast Report 2025-2033: Surge in mRNA-Based Therapeutics & Vaccines, Technology Innovation & Outsourcing Trends
globenewswire.com
BNTX
MRNA
CURE
The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
globenewswire.com
ONCY
IBRX
BNTX
CMPX
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
BNTX
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
Cell and Gene Therapy Market Projected to Reach US$ 183.1 Billion by 2035, Supported by Expanding Global Clinical Trial Activity Says Astute Analytica
globenewswire.com
NVS
ABBV
BNTX
LLY
BMY
GILD
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
globenewswire.com
BNTX
CVAC
BMY